Norwegian Veterinary Institute, P.O. Box 750 Sentrum, 0106 Oslo, Norway.
Biotechnol Adv. 2012 Nov-Dec;30(6):1318-35. doi: 10.1016/j.biotechadv.2012.01.024. Epub 2012 Feb 3.
Genetically modified plants, in the following referred to as genetically modified organisms or GMOs, have been commercially grown for almost two decades. In 2010 approximately 10% of the total global crop acreage was planted with GMOs (James, 2011). More than 30 countries have been growing commercial GMOs, and many more have performed field trials. Although the majority of commercial GMOs both in terms of acreage and specific events belong to the four species: soybean, maize, cotton and rapeseed, there are another 20+ species where GMOs are commercialized or in the pipeline for commercialization. The number of GMOs cultivated in field trials or for commercial production has constantly increased during this time period. So have the number of species, the number of countries involved, the diversity of novel (added) genetic elements and the global trade. All of these factors contribute to the increasing complexity of detecting and correctly identifying GMO derived material. Many jurisdictions, including the European Union (EU), legally distinguish between authorized (and therefore legal) and un-authorized (and therefore illegal) GMOs. Information about the developments, field trials, authorizations, cultivation, trade and observations made in the official GMO control laboratories in different countries around the world is often limited, despite several attempts such as the OECD BioTrack for voluntary dissemination of data. This lack of information inevitably makes it challenging to detect and identify GMOs, especially the un-authorized GMOs. The present paper reviews the state of the art technologies and approaches in light of coverage, practicability, sensitivity and limitations. Emphasis is put on exemplifying practical detection of un-authorized GMOs. Although this paper has a European (EU) bias when examples are given, the contents have global relevance.
经过近二十年的商业化种植,转基因植物(以下简称转基因生物或 GMO)已经得到广泛应用。2010 年,全球约有 10%的作物种植面积种植了转基因作物(James,2011)。超过 30 个国家种植了商业化的转基因作物,还有更多的国家进行了田间试验。尽管在种植面积和具体事件方面,大多数商业化的转基因作物都属于大豆、玉米、棉花和油菜这四个物种,但还有另外 20 多种物种的转基因作物已经商业化或正在进行商业化开发。在此期间,田间试验或商业生产中种植的转基因作物数量不断增加。参与的物种数量、国家数量、新型(添加)遗传元件的多样性和全球贸易也在不断增加。所有这些因素都增加了检测和正确识别转基因生物衍生材料的复杂性。包括欧盟(EU)在内的许多司法管辖区在法律上区分了授权(因此合法)和未授权(因此非法)的转基因生物。尽管有一些尝试,如经合组织的 BioTrack 自愿传播数据,但关于世界各地不同国家的官方转基因生物监管实验室的发展、田间试验、授权、种植、贸易和观察的信息往往是有限的。这种信息的缺乏不可避免地给检测和识别转基因生物,特别是未经授权的转基因生物带来了挑战。本文综述了现有技术和方法,重点介绍了其实用性、敏感性和局限性。强调了实际检测未经授权的转基因生物的实例。虽然本文在举例时存在欧洲(EU)偏见,但内容具有全球相关性。